Balboa Wealth Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Balboa Wealth Partners’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-3,550	Closed	-$320K	–	376
2024 Q4	$320K	Sell	3,550 -125	-3%	-$12.1K	0.07%	199
2024 Q3	$363K	Hold	3,675	–	–	0.09%	171
2024 Q2	$341K	Sell	3,675 -3,545	-49%	-$318K	0.09%	173
2024 Q1	$685K	Sell	7,220 -425	-6%	-$39.4K	0.2%	95
2023 Q4	$683K	Hold	7,645	–	–	0.23%	86
2023 Q3	$558K	Sell	7,645 -716	-9%	-$57.2K	0.21%	88
2023 Q2	$696K	Sell	8,361 -102	-1%	-$8.53K	0.24%	73
2023 Q1	$645K	Buy	8,463 +678	+9%	+$56.3K	0.24%	79
2022 Q4	$646K	Sell	7,785 -130	-2%	-$10.5K	0.29%	83
2022 Q3	$628K	Buy	+7,915	New	+$667K	0.28%	73

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Balboa Wealth Partners's XBI Position: Q1 2025 in Review

Balboa Wealth Partners sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2025, closing a stake of 3,550 shares — an estimated $320K sold.

Balboa Wealth Partners first reported a position in XBI in Q3 2022 and held it in 10 quarters. The position peaked at $696K in Q2 2023. 685 funds tracked by Wall St. Rank hold XBI as of Q1 2025.

Balboa Wealth Partners reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2025 after selling out during the quarter.
Balboa Wealth Partners sold 3,550 State Street SPDR S&P Biotech ETF shares in Q1 2025, an estimated $320K.
Balboa Wealth Partners first reported a position in State Street SPDR S&P Biotech ETF in Q3 2022 and held it in 10 quarters.
Balboa Wealth Partners's State Street SPDR S&P Biotech ETF position peaked at $696K in Q2 2023.
685 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2025.

Based on Balboa Wealth Partners's 13F filing for Q1 2025, filed 23 Apr 2025.